Expressive Writing for COVID-19 Resilience

Completed · Not applicable

Conditions studied: Distress Due to COVID-19

In brief

The purpose of this study is to determine the impact of a 6-week, virtually-delivered expressive writing intervention on resilience in a cohort of individuals currently navigating the COVID-19 pandemic during spring 2020.

Key facts

Study ID

NCT04589104

Run by

Duke University

People needed

63

Starts

2020-05-26

Expected to finish

2020-08-17

Last updated by the study team

2020-10-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Potential subjects will be considered eligible if they feel they have been personally impacted by circumstances surrounding COVID-19. Other eligibility criteria include:
• Able to speak, read, write, and understand English
• Cognitively able to provide consent
• Ability to participate in a 6-week intervention delivered via Zoom, REDCap, and email

Where it is running

• Duke Integrative Medicine — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.